Back in April 2020, AstraZeneca was hailed as a frontrunner in the race to get an effective vaccine to market. A year later, after a series of trial pauses, communication blunders, and PR problems, the vaccine is on the cusp of FDA approval.
By all accounts, the company succeeded in making a safe, effective vaccine. So why has there been so much confusion about its rollout?
Guest:
Peter Aldhous, science reporter at Buzzfeed News
Host
Lizzie O’Leary
Hosted on Acast. See acast.com/privacy for more information.
